造影乳房X光攝影市場規模、佔有率及成長分析（按應用、最終用戶和地區）- 產業預測 2025-2032

預計造影X 光乳房X光攝影市場規模將在 2023 年達到 23 億美元，2024 年達到 24.4 億美元，到 2032 年達到 38.9 億美元，預測期內（2025-2032 年）的複合年成長率為 6.0%。

造影乳房X光攝影靶X光檢查（CEM）利用雙能量技術，有效結合了數位化乳癌乳房X光攝影X光檢查和靜脈造影的優勢，在診斷場景中比全數位化乳房乳房X光攝影X光檢查（FFDM）和超音波在乳癌檢測中表現出更高的靈敏度。鑑於全球乳癌發生率不斷上升，且老齡化、肥胖和家族病史等風險因素加劇了這一趨勢，CEM 的普及度急劇上升，目前已成為主要的影像技術。大多數乳癌病例主要影響女性，凸顯了龐大的市場需求。乳房腫塊、大小或形狀的變化以及分泌物等症狀凸顯了有效檢測解決方案的緊迫性。因此，乳癌率的上升繼續推動先進影像技術市場的成長。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 二次資料和一次資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態與展望

• 市場概覽
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024年）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 定價分析

造影乳房X光攝影市場規模（按應用分類）及複合年成長率（2025 年至 2032 年）

• 市場概覽
• 篩檢
• 診斷

造影乳房X光攝影市場規模（以最終用戶分類）及複合年成長率（2025 年至 2032 年）

• 市場概覽
• 醫院
• 診斷中心
• 專科診所
• 其他

造影乳房X光攝影市場規模（按地區）及複合年成長率（2025 年至 2032 年）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024年）
• 主要企業簡介
  • 公司詳情
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• GE Healthcare（USA）
• Siemens Healthineers（Germany）
• Hologic, Inc.（USA）
• Fujifilm Holdings Corporation（Japan）
• Canon Medical Systems Corporation（Japan）
• Philips Healthcare（Netherlands）
• Carestream Health（USA）
• Konica Minolta, Inc.（Japan）
• Planmed Oy（Finland）
• Sectra AB（Sweden）
• Gamma Medica-Ideas, Inc.（USA）
• SuperSonic Imagine（France）
• iCAD, Inc.（USA）
• ScreenPoint Medical（Netherlands）
• DeepHealth（USA）
• Lunit Inc.（South Korea）
• CureMetrix, Inc.（USA）
• Bracco Imaging SpA（Italy）
• Guerbet（France）

結論和建議

Contrast Enhanced Mammography Market size was valued at USD 2.3 billion in 2023 and is poised to grow from USD 2.44 billion in 2024 to USD 3.89 billion by 2032, growing at a CAGR of 6.0% during the forecast period (2025-2032).

By leveraging a dual-energy technique, Contrast-Enhanced Mammography (CEM) effectively merges the advantages of digital mammography with intravenous contrast, showcasing superior sensitivity in breast cancer detection compared to Full-Field Digital Mammography (FFDM) and ultrasound in diagnostic scenarios. Given the escalating global prevalence of breast cancer-exacerbated by risk factors such as age, obesity, and a family history of the disease-CEM has surged in popularity and is now a leading imaging technique. The majority of breast cancer cases, primarily affecting females, highlight significant market demand. Symptoms like breast lumps, changes in size and shape, and fluid discharge underscore the urgency for effective detection solutions. Consequently, the increasing incidence of breast cancer continues to propel market growth for advanced imaging technologies.

Top-down and bottom-up approaches were used to estimate and validate the size of the Contrast Enhanced Mammography market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Contrast Enhanced Mammography Market Segments Analysis

Global Contrast Enhanced Mammography Market is segmented by Applications, End User and region. Based on Applications, the market is segmented into Screening and Diagnosis. Based on End User, the market is segmented into Hospital, Diagnostic Centres, Specialty Clinics and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Contrast Enhanced Mammography Market

The Contrast Enhanced Mammography market is primarily driven by the increasing prevalence of breast cancer, which stands as the most frequently diagnosed cancer among women globally. Early detection of breast cancer significantly enhances treatment efficacy, allowing for improved patient outcomes. Typically, treatment regimens for breast cancer patients encompass a combination of surgery, radiation therapy, and various medications, including hormone therapy, chemotherapy, and targeted biological therapies. These interventions are crucial in managing the disease, as they not only halt the progression of cancer but also reduce the risk of metastasis, ultimately contributing to higher survival rates and better quality of life for affected individuals.

Restraints in the Contrast Enhanced Mammography Market

The Contrast Enhanced Mammography market faces several significant barriers that could hinder its growth and adoption. Firstly, being a relatively novel technology, the costs associated with the equipment, materials, and necessary training are considerably higher than those for traditional mammography, posing a financial challenge for healthcare providers. Additionally, the limited availability of facilities offering this advanced imaging technique makes it difficult for patients, especially in rural or remote regions, to access these services. Furthermore, obtaining regulatory approval for clinical use is often a lengthy and costly process, potentially delaying market entry. Lastly, despite the encouraging results from clinical studies, the absence of long-term data on the technology's safety and effectiveness may lead some healthcare professionals to exercise caution in embracing this advancement until more substantial evidence is presented.

Market Trends of the Contrast Enhanced Mammography Market

The Contrast Enhanced Mammography (CEM) market is experiencing robust growth, driven by the increasing incidence of breast cancer among women and the demand for advanced diagnostic techniques. As healthcare providers adopt state-of-the-art technologies for early detection, CEM stands out for its superior sensitivity and specificity compared to traditional methods. This trend is fueled by the desire for more accurate and timely results, enabling better treatment decisions. Enhanced imaging technologies not only improve diagnostic performance but also instill greater confidence among patients and healthcare professionals, ultimately propelling market expansion and innovation in breast cancer management solutions.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Contrast Enhanced Mammography Market Size by Applications & CAGR (2025-2032)

• Market Overview
• Screening
• Diagnosis

Global Contrast Enhanced Mammography Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospital
• Diagnostic Centres
• Specialty Clinics
• Others

Global Contrast Enhanced Mammography Market Size & CAGR (2025-2032)

• North America (Applications, End User)
  • US
  • Canada
• Europe (Applications, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Applications, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Applications, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Applications, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• GE Healthcare (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fujifilm Holdings Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Canon Medical Systems Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Philips Healthcare (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Carestream Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Konica Minolta, Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Planmed Oy (Finland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sectra AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gamma Medica-Ideas, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SuperSonic Imagine (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• iCAD, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ScreenPoint Medical (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DeepHealth (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lunit Inc. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CureMetrix, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bracco Imaging S.p.A. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Guerbet (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations